close
close

Manufacturers of popular diabetes and weight loss drugs questioned over high costs in the US

IE 11 is not supported. For an optimal experience, please visit our site with another browser.

  • Biden says in his last UN speech that the world is at a “turning point”

    02:09

  • The upswing in women’s basketball also extends to spontaneous games in the neighborhood

    01:44

  • Now running

    Manufacturers of popular diabetes and weight loss drugs questioned over high costs in the US

    02:23

  • Next

    Justice Department accuses Visa of monopolizing debit card transactions

    01:09

  • Families of the hostages talk about frustration, hope and the emotional strain of the ordeal

    04:28

  • Tropical Storm Helene is likely to quickly develop into a severe hurricane

    00:56

  • Israel bombs southern Lebanon and Beirut for second day

    02:11

  • Former hostage: “I thought the whole time I was going to die”

    01:19

  • Good news: Mother whose limbs were amputated gets a new home

    01:56

  • San Francisco takes action against deepfake websites

    03:01

  • Trump focuses on immigrants in Pennsylvania

    02:26

  • New details revealed about alleged assassination attempt on Trump

    01:43

  • Lebanese authorities say hundreds of people have been killed in Israeli air strikes

    02:14

  • Iran's new vice president says Iran does not want a major war

    01:38

  • New polls show shifts in racial distribution nationally and in key battlegrounds

    02:01

  • High school football player surprises teammates with special gift

    02:30

  • Behind the scenes of the NFL's facial authentication technology

    02:36

  • A look behind the scenes of security preparations for the UN General Assembly

    02:29

  • Newly released body camera footage shows a police-involved shooting in the New York subway

    01:34

  • Donald Trump campaigns in contested North Carolina

    02:07

Novo Nordisk's CEO was asked about the high cost of Wegovy and Ozempic, diabetes and weight loss drugs that are extremely popular in the US. Lars Jorgensen said pharmacy benefit managers are largely to blame. NBC News' Stephanie Gosk reports.